Skip to main content
Evidence-Ranked Guide

Best Peptides for Healing & Recovery

BPC-157 and TB-500 lead a tissue-repair list grounded in wound-healing and angiogenesis research.

Healing and recovery peptides target tissue repair through angiogenesis, cell migration and anti-inflammatory signalling. We ranked by published wound-repair evidence — clinical-tagged where it exists — then by how well the mechanism is characterised. BPC-157 and TB-500 anchor the list with the deepest catalogues, while GHK-Cu, KPV, ARA-290 and LL-37 cover skin, gut and immune-mediated healing. All are research compounds; several are WADA-banned for athletes.

The Ranked List

#1
BPC-157Research WADA banned

Body-protection compound with clinical-tagged evidence for skin, tendon, ligament and GI-tract healing via VEGF/angiogenesis — 15 catalogued benefits; no human clinical trials have been completed.

Reported dose: 200–500 mcg daily (SC/oral)

Half-life: <30 minutes

Route: SC/Oral

Read the full BPC-157 guide →
#2
TB-500Research WADA banned

Thymosin beta-4 fragment that supports cell migration and angiogenesis; clinical-tagged wound-healing and cardiac-repair benefits in the catalogue.

Reported dose: 2–8 mg 2–3×/week (SC)

Half-life: Variable

Route: SC

Read the full TB-500 guide →
#3
GHK-CuResearch WADA banned

Copper tripeptide with clinical-tagged skin-regeneration data (collagen and GAG synthesis) plus preclinical diabetic-wound healing; used topically at 1% or injected in research.

Reported dose: 1% topical or 1–2 mg SC

Half-life: Minutes to hours

Route: Topical/SC

Read the full GHK-Cu guide →
#4
KPVResearch

Anti-inflammatory tripeptide with clinical-tagged corneal and diabetic-wound healing plus PepT1-mediated NF-κB inhibition in IBD/colitis models.

Reported dose: 200–500 mcg daily

Half-life: Short

Route: SC/Oral

Read the full KPV guide →
#5
ARA-290Research

Non-erythropoietic EPO derivative focused on nerve repair and neuropathic pain; its catalogued evidence is largely anecdotal-tier so far.

Reported dose: 1–4 mg 3× weekly (SC)

Half-life: 4-6 hours

Route: SC

Read the full ARA-290 guide →
#6
LL-37Research WADA banned

Antimicrobial peptide with clinical-tagged ulcer-healing data (68% mean ulcer-area decrease in one study); WADA-banned for athletes.

Reported dose: 50–200 mcg daily

Half-life: Short

Route: SC/Topical

Read the full LL-37 guide →

Safety Note

Most compounds on this page are prescription drugs or research chemicals — not supplements. None of this content is medical advice: review each compound's full guide and safety note, respect WADA status if you compete, and consult a qualified clinician before making any health decision.

Frequently Asked Questions

What is the most-studied healing peptide?

BPC-157: 15 catalogued benefits, including clinical-tagged wound-healing through VEGF-driven angiogenesis, tendon and ligament repair, and GI-tract protection. Its safety note is also honest — no human clinical trials have been completed.

Can BPC-157 and TB-500 be stacked?

They are commonly researched together: BPC-157 for localised tissue repair and TB-500 for systemic cell migration and angiogenesis. Both are WADA-banned, so athletes must avoid them.

Are any of these FDA approved?

No — all six are research compounds. GHK-Cu has the longest cosmetic use history (topical 1% for skin), but injectable use remains research-grade.

Which is best for gut versus tendon issues?

BPC-157 has the strongest GI-tract and tendon/ligament catalogue; KPV targets gut inflammation via PepT1-mediated NF-κB inhibition; TB-500 and ARA-290 are more systemic in scope.

Where Researchers Source Compounds

If you are exploring these compounds in a legitimate research setting, our partner store Peptide Hackers carries catalog-grade research peptides with third-party testing. We only link to suppliers we trust.

Visit Peptide Hackers →

Other Goals

Research purposes only. This ranking reflects the depth of published and catalogued evidence, not a recommendation to use any compound. Most peptides here are not approved for human use; always consult qualified medical professionals before making health decisions.